Zobrazeno 1 - 10
of 33 792
pro vyhledávání: '"R Feldman"'
Publikováno v:
Modern Language Review, 2018 Jan 01. 113(1), 230-231.
Externí odkaz:
https://www.jstor.org/stable/10.5699/modelangrevi.113.1.0230
Autor:
Douglas Mao
Publikováno v:
Modernism/modernity. 29:885-887
Evaluation of public perception towards patients with hidradenitis suppurativa and atopic dermatitis
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 5, Pp 1682-1685 (2024)
Externí odkaz:
https://doaj.org/article/818d3a8d75b84b368e7651dd559f50cb
Autor:
Richard S. Matulewicz, Fady Baky, Andrea Knezevic, Joel Sheinfeld, Brandon M. Williams, Rachel E. Kantor, Nicole Liso, Jahwa Hossain, Maria Bromberg, Alisa Valentino, Rachel So, Samuel A. Funt, Fei Ye, Darren R. Feldman
Publikováno v:
European Urology Open Science, Vol 68, Iss , Pp 1-9 (2024)
Background: MicroRNAs (miRNAs) show promise as blood-based tumor markers for germ cell tumors (GCTs), with miRNA-371-3p being the most studied. The marginal benefit of including other candidate miRNAs to aid with the management of testicular GCTs rem
Externí odkaz:
https://doaj.org/article/57a3806f22b54971b715cd62cc504717
Autor:
Geert Lernout
Publikováno v:
James Joyce Quarterly. 59:527-530
Autor:
Mathias Tiedemann Svendsen, MD, PhD, Klaus Ejner Andersen, MD, DMSc, Steven R. Feldman, MD, PhD, Sören Möller, MSc, PhD, Line Planck Kongstad, MSc, PhD, Anna Mejldal, MSc, PhD
Publikováno v:
JAAD International, Vol 17, Iss , Pp 160-162 (2024)
Externí odkaz:
https://doaj.org/article/9cfbf1efabba41b59c0f9608c5e43230
Autor:
Newlyn, Lucy
Publikováno v:
The Review of English Studies, 1999 Aug 01. 50(199), 393-396.
Externí odkaz:
https://www.jstor.org/stable/517907
Autor:
Behrendt, Stephen C.
Publikováno v:
The Wordsworth Circle, 2016 Oct 01. 47(4), 158-161.
Externí odkaz:
https://www.jstor.org/stable/26389504
Autor:
Gaurav N. Pathak, Anurag N. Pathak, Vibha Mital, Jimmy Dhillon, Steven R. Feldman, Babar K. Rao
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/34cc62bfbf594ecf8af0af70032b5f3c
Autor:
Steven R. Feldman, Joanna Narbutt, Giampiero Girolomoni, Jan Brzezicki, Nataliya Reznichenko, Maria Agnieszka Zegadło-Mylik, Grazyna Pulka, Magdalena Dmowska-Stecewicz, Elżbieta Kłujszo, Dmytro Rekalov, Lidia Rajzer, Jiyoon Lee, Minkyung Lee, Young Hee Rho
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Introduction SB17 is a biosimilar to reference ustekinumab (UST). We compared the efficacy, safety, and immunogenicity of SB17 to UST up to Week 52, including switching from UST to SB17.Methods Subjects were randomized to receive 45 mg of SB17 or UST
Externí odkaz:
https://doaj.org/article/6c23eae0b2e24e7484f961e0f4edf041